|
|
Volumn 14, Issue 4, 2004, Pages 529-535
|
|
Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CD51 ANTIGEN;
DOXORUBICIN;
DOXORUBUCIN CYSTEINYL ASPARTYL CYSTEINYL ARGINYL GLYCYL ASPARTYL CYCSTEINYL PHENYLALANYL CYSTEINE CONJUGATE;
DOXORUBUCIN CYSTEINYL-ASPARTYL-CYSTEINYL-ARGINYL-GLYCYL-ASPARTYL-CYCSTEINYL-PHENYLALANYL-CYSTEINE CONJUGATE;
DRUG DERIVATIVE;
OLIGOPEPTIDE;
VITRONECTIN RECEPTOR;
ANIMAL;
ARTICLE;
CANCER TRANSPLANTATION;
CHEMICAL STRUCTURE;
CHEMISTRY;
DISEASE MODEL;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
IMMUNOHISTOCHEMISTRY;
LIVER CELL CARCINOMA;
MALE;
METABOLISM;
MOUSE;
PATHOLOGY;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
CELL LINE, TUMOR;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DISEASE MODELS, ANIMAL;
DOXORUBICIN;
IMMUNOHISTOCHEMISTRY;
INTEGRIN ALPHAV;
INTEGRIN ALPHAVBETA3;
MALE;
MICE;
MOLECULAR STRUCTURE;
NEOPLASM TRANSPLANTATION;
OLIGOPEPTIDES;
MLCS;
MLOWN;
|
|
EID: 16644385119
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.14.4.529 Document Type: Article |
|
Times cited : (45)
|
|
References (0)
|
